The Storm in Biotech: What’s Causing High-Flying Stocks to Plummet?
Early-stage biotech companies, including Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics, faced significant stock declines, with Biohaven down 35.3% in March's closing quarter. Biotech firms, often investment-heavy and loss-making, are struggling…